(2021) Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. Infection Control and Hospital Epidemiology. pp. 118-119. ISSN 0899-823X
Full text not available from this repository.
Abstract
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
| Item Type: | Article |
|---|---|
| Keywords: | Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox |
| Subjects: | WC Communicable Diseases > WC 500-590 Virus Diseases Cardiovascular System |
| Divisions: | Cardiovascular Research Institute > Applied Physiology Research Center Cardiovascular Research Institute > Heart Failure Research Center Cardiovascular Research Institute > Isfahan Cardiovascular Research Center |
| Page Range: | pp. 118-119 |
| Journal or Publication Title: | Infection Control and Hospital Epidemiology |
| Journal Index: | ISI |
| Volume: | 42 |
| Number: | 1 |
| Identification Number: | https://doi.org/10.1017/ice.2020.195 |
| ISSN: | 0899-823X |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/14554 |
Actions (login required)
 |
View Item |